v3.26.1
Summary of Significant Accounting Policies (Details) - USD ($)
 12 Months Ended
Feb. 28, 2026
Feb. 28, 2025
Mar. 31, 2023
Dec. 31, 2025
May 31, 2025
Dec. 31, 2024
May 31, 2024
Dec. 31, 2023
Nov. 30, 2025
Summary of Significant Accounting Policies [Line Items]                  
Allowance for credit losses               $ 521,007  
Allowance for credit losses           522,191  
Estimated useful life       5 years          
Lease term       12 months          
Written-down of inventories           13,206  
Vesting period term     6 months            
Management approach to determine reportable segments description       The Group operates and manages its business as a single operating and reportable segment. The Group’s CODM has been identified as the Chief Executive Officer who reviews the consolidated net income (loss) when making decisions about allocating resources and assessing performance of the Group.          
Executive Chairman       Executive Chairman          
Related Parties [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
Allowance for credit losses       $ 522,191   522,191      
Government Subsidies [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
Written-down of inventories         $ 0.9    
DiamiR Biosciences Corp. [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
Management approach to determine reportable segments description         The Company performs research and development activities of its own and for others substantially in one location using resources common to internal research activities and revenue-producing services, which have been limited to date.        
Executive Chairman         Executive Chairman        
FDIC insured limits         $ 250,000        
Other revenue   $ 100,000              
Cash equivalents              
Impairment charges on long-lived assets              
DiamiR Biosciences Corp. [Member] | Subsequent Event [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
Other revenue $ 60,000                
Accounts receivable $ 107,400                
Minimum [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
Vesting period term       9 months 15 days          
Maximum [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
Vesting period term       21 months 15 days          
Maximum [Member] | DiamiR Biosciences Corp. [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
FDIC insured limits                 $ 250,000
Unbilled Revenues [Member] | DiamiR Biosciences Corp. [Member]                  
Summary of Significant Accounting Policies [Line Items]                  
Contract asset           $ 89,281